Professor Christos Toumpanakis

Professor Christos Toumpanakis is an internationally recognised specialist in neuroendocrine tumours (NETs) and Consultant Gastroenterologist at the Royal Free Hospital, London, which houses the internationally recognised, largest European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, in Europe. He is also Professor of Gastroenterology & Neuroendocrine Tumours at University College London (UCL).

He graduated from the University of Athens Medical School in 1994, completed his specialist training in Gastroenterology and Hepatology in 2004, and was awarded his PhD by the University of Athens in 2007.

With extensive experience in the diagnosis and management of all types of gastroenteropancreatic and bronchial NETs, Professor Toumpanakis provides expert assessment and individualised treatment for patients at every stage of their disease. His clinical expertise encompasses the full range of available NET treatments, including somatostatin analogues, targeted therapies, peptide receptor radionuclide therapy (PRRT), chemotherapy and multidisciplinary approaches to complex disease.

He has a particular interest in helping patients navigate the often complex decisions involved in NET management, including treatment selection and sequencing, advanced disease, treatment-related symptoms and long-term disease monitoring. He works closely with a highly experienced multidisciplinary team to ensure that each patient benefits from a comprehensive and coordinated approach to care.

Professor Toumpanakis believes that excellent medical care goes beyond treating the disease. He places great importance on listening to patients, understanding their individual circumstances, concerns and priorities, and developing a personalised management plan in partnership with them. His approach is characterised by warmth, accessibility and clear communication, ensuring that patients feel informed, supported and actively involved in decisions about their care. He recognises that living with a NET can affect many aspects of a person's life and that addressing these wider needs is an essential part of treatment.

Professor Toumpanakis is actively involved in international NET research and education. He leads a clinical research group at the Royal Free Hospital, with particular interests in novel biomarkers, molecular imaging, mesenteric fibrosis and carcinoid heart disease. He has authored or co-authored more than 160 scientific publications, with an H-index of 45, and regularly lectures at major national and international conferences.

He has held several leadership roles within the European Neuroendocrine Tumour Society (ENETS), including Chair of its Advisory Board, and has contributed to the development of ENETS, UK and Ireland NET clinical guidelines. He is also Editor of the ENETS Continuing Medical Education (CME) programme, supporting the education and development of healthcare professionals involved in NET care.

Professor Toumpanakis is committed to medical education and has received the prestigious Top Teacher of the Year award at UCL in 2007, 2009, 2013, 2014, 2015 and 2016.

Alongside his specialist NET practice, his broader gastroenterology interests include gastro-oesophageal reflux disease, coeliac disease, chronic diarrhoea, inflammatory bowel disease and gastrointestinal complications in patients with congenital immunodeficiencies.

Prof Toumpanakis’ LinkedIn profile can be viewed using the following link: https://uk.linkedin.com/in/christos-toumpanakis-16642b38(opens in new tab)

To view video content on Dr Toumpanakis and his work, please visit YouTube using the links below: